Chronic Leukemia Perspective
- Signal Disruption: Targeted Therapies for CLL: New Targets, New Approaches
- Highlights in Chronic Lymphocytic Leukemia From ASH 2020
- Signal Disruption: Targeted Therapies for CLL: The Greater Good
- Signal Disruption: Targeted Therapies for CLL: What Patients Want
- Signal Disruption: Targeted Therapies for CLL: Choosing From the Combo Menu
- A 70-Year-Old Man With Splenomegaly
- A 71-Year-Old Man With Malaise and Weight Loss
- Signal Disruption: Flipping the Switch
- EHA 2020
- With 'Horrendous' Decisions Afoot in COVID-19, Teams Are Key
- Treatment Tips in Chronic Lymphocytic Leukemia
- Signal Disruption: Targeted Therapies for CLL
- Targeted Therapy for CLL: Beyond Chemotherapy: New Targeted Agents
- CLL Highlights From ASH 2019
- The 8 Most Notable Cancer Clinical Trials of 2019
- Emerging Trends: Targeted Therapy for CLL: FISHing for Risk Markers
- Chronic Lymphocytic Leukemia: 5 Things to Know
- Emerging Trends: Targeted Therapy for CLL
- EHA 2019
- BSH 2019